A former AstraZeneca Pharmaceuticals, LP employee won $2.4 million in damages after being fired for raising the alarm that an executive was marketing drugs for unapproved uses.
AstraZeneca violated Oregon’s whistleblower statute, which protects employees from facing retaliation for good-faith reporting of wrongdoing, the federal court jury found. It awarded plaintiff Suzanne Ivie $510,423 in back pay and $1,872,000 for emotional distress, suffering, and reputational harm.
The jury did not find Ivie’s claims of age and employment discrimination or retaliation supported by evidence, according to its verdict rendered Tuesday in the U.S. District Court for the District of Oregon at ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
